Sitrin Capital Management LLC Amgen Inc Transaction History

Sitrin Capital Management LLC

$200 Million
Q3 2024

A detailed history of Sitrin Capital Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Sitrin Capital Management LLC holds 22,550 shares of AMGN stock, worth $5.92 Million. This represents 3.63% of its overall portfolio holdings.

Number of Shares

22,550

Previous 22,638 0.39%

Holding current value

$5.92 Million

Previous $7.07 Million 2.71%

% of portfolio

3.63%

Previous 3.76%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$309.38 - $337.38 $27,225 - $29,689	-88 Reduced 0.39%	22,550 $7.27 Million
Q2 2024 Jul 12, 2024	BUY	$262.75 - $319.31 $17,078 - $20,755	65 Added 0.29%	22,638 $7.07 Million
Q1 2024 Apr 29, 2024	SELL	$268.87 - $324.56 $62,915 - $75,947	-234 Reduced 1.03%	22,573 $6.42 Million
Q4 2023 Jan 24, 2024	SELL	$255.7 - $288.46 $81,568 - $92,018	-319 Reduced 1.38%	22,807 $6.57 Million
Q3 2023 Oct 26, 2023	SELL	$218.65 - $271.46 $579,641 - $719,640	-2,651 Reduced 10.28%	23,126 $6.22 Million
Q2 2023 Aug 02, 2023	BUY	$214.27 - $253.37 $61,495 - $72,717	287 Added 1.13%	25,777 $5.72 Million
Q1 2023 Apr 24, 2023	SELL	$225.79 - $275.2 $41,996 - $51,187	-186 Reduced 0.72%	25,490 $6.16 Million
Q4 2022 Jan 18, 2023	SELL	$229.03 - $291.01 $272,774 - $346,592	-1,191 Reduced 4.43%	25,676 $0
Q3 2022 Oct 13, 2022	BUY	$224.46 - $253.15 $74,296 - $83,792	331 Added 1.25%	26,867 $6.06 Million
Q2 2022 Jul 22, 2022	SELL	$230.71 - $256.74 $122,507 - $136,328	-531 Reduced 1.96%	26,536 $6.46 Million
Q1 2022 Apr 19, 2022	BUY	$219.27 - $242.57 $17,322 - $19,163	79 Added 0.29%	27,067 $6.55 Million
Q4 2021 Jan 18, 2022	BUY	$198.88 - $227.6 $18,495 - $21,166	93 Added 0.35%	26,988 $6.07 Million
Q3 2021 Nov 05, 2021	BUY	$212.27 - $248.7 $3,608 - $4,227	17 Added 0.06%	26,895 $5.72 Million
Q2 2021 Jul 22, 2021	SELL	$233.58 - $259.14 $342,661 - $380,158	-1,467 Reduced 5.18%	26,878 $6.55 Million
Q1 2021 Apr 29, 2021	SELL	$221.91 - $258.6 $33,730 - $39,307	-152 Reduced 0.53%	28,345 $7.05 Million
Q4 2020 Feb 02, 2021	BUY	$216.38 - $257.67 $27,263 - $32,466	126 Added 0.44%	28,497 $6.55 Million
Q3 2020 Oct 23, 2020	BUY	$234.65 - $260.95 $34,728 - $38,620	148 Added 0.52%	28,371 $6.96 Million
Q2 2020 Aug 06, 2020	SELL	$197.81 - $242.74 $362,190 - $444,456	-1,831 Reduced 6.09%	28,223 $6.66 Million
Q1 2020 May 11, 2020	SELL	$182.24 - $241.7 $375,778 - $498,385	-2,062 Reduced 6.42%	30,054 $6.09 Million
Q4 2019 Jan 14, 2020	SELL	$189.21 - $243.2 $20,623 - $26,508	-109 Reduced 0.34%	32,116 $7.74 Million
Q3 2019 Oct 22, 2019	SELL	$174.11 - $208.62 $28,379 - $34,005	-163 Reduced 0.5%	32,225 $6.24 Million
Q2 2019 Jul 17, 2019	SELL	$166.7 - $195.41 $51,677 - $60,577	-310 Reduced 0.95%	32,388 $5.97 Million
Q1 2019 Apr 11, 2019	BUY	$180.87 - $203.88 $48,473 - $54,639	268 Added 0.83%	32,698 $6.21 Million
Q4 2018 Jan 22, 2019	BUY	$178.4 - $208.25 $60,120 - $70,180	337 Added 1.05%	32,430 $6.31 Million
Q3 2018 Oct 17, 2018	BUY	$185.29 - $208.89 $123,773 - $139,538	668 Added 2.13%	32,093 $6.65 Million
Q2 2018 Jul 25, 2018	BUY	$166.05 - $186.51 $309,351 - $347,468	1,863 Added 6.3%	31,425 $5.8 Million
Q1 2018 Apr 17, 2018	BUY	$169.43 - $198.0 $14,062 - $16,434	83 Added 0.28%	29,562 $5.04 Million
Q4 2017 Feb 08, 2018	SELL	$168.79 - $188.59 $70,047 - $78,264	-415 Reduced 1.39%	29,479 $5.13 Million
Q3 2017 Oct 27, 2017	SELL	$167.29 - $191.0 $53,867 - $61,502	-322 Reduced 1.07%	29,894 $5.57 Million
Q2 2017 Aug 07, 2017	BUY	N/A	30,216	30,216 $5.2 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $140B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sitrin Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sitrin Capital Management LLC with notifications on news.

Account

Sitrin Capital Management LLC Amgen Inc Transaction History